Press Releases

Press Releases

Apr 15, 2019
Data Supports Achievement of Proof-of-Concept Milestone for OTL-300 BOSTON and LONDON , April 15, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare